Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case–control studies Abdolkarim Moazeni-RoodiSaeid GhavamiMohammad Hashemi Review Article 12 February 2019 Pages: 335 - 349
To what extent does the EQ-5D-3L correlate with the FACT-H&N of patients with oral cancer during the perioperative period? Takayuki AokiYoshihide OtaTakeru Shiroiwa Original Article 03 November 2018 Pages: 350 - 358
Genetic association of promoter in GRP78 gene with nasopharyngeal carcinoma in a Chinese population Rong WangHai-Mei QinJun-Li Wang Original Article 09 November 2018 Pages: 359 - 365
Prognostic impact of underlying lung disease in pulmonary wedge resection for lung cancer Takeshi KawaguchiNoriyoshi SawabataShigeki Taniguchi Original Article 15 November 2018 Pages: 366 - 374
Histologic transformation of non-small-cell lung cancer in brain metastases Meng JiangXiaolong ZhuXiao Ding Original Article 16 November 2018 Pages: 375 - 384
Verification of the diagnostic strategy for anterior mediastinal tumors Shuhei HakiriKoji KawaguchiKohei Yokoi Original Article 29 October 2018 Pages: 385 - 393
The effects of intraoperative ICG fluorescence angiography in laparoscopic low anterior resection: a propensity score-matched study Toshiaki WadaKenji KawadaYoshiharu Sakai Original Article 08 November 2018 Pages: 394 - 402
Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial Akihiro TomidaKeisuke UeharaOf the Nagoya Surgical Oncology Group Original Article 23 November 2018 Pages: 403 - 410
The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study Aristotelis BamiasVasilios KaravasilisMeletios-Athanasios Dimopoulos Original Article 29 October 2018 Pages: 411 - 419
Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites Yoshiko KawataKazunori NagasakaTomoyuki Fujii Original Article 24 November 2018 Pages: 420 - 427
Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer Yasunori YoshinoAyumi TaguchiToshiharu Yasugi Original Article 30 November 2018 Pages: 428 - 436
Body composition as a predictor of toxicity after treatment with eribulin for advanced soft tissue sarcoma Hiroshi KobayashiTomotake OkumaSakae Tanaka Original Article 21 November 2018 Pages: 437 - 444
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial) Shin FujisawaYasunori UedaShinya Kimura Original Article Open access 12 November 2018 Pages: 445 - 453
Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer Shuji HiramotoTomoko TamakiAkira Inoue Original Article 30 October 2018 Pages: 454 - 459